El‐Shaimaa A. Arafa
Impact in
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents
-
- Nigella sativa pharmacological applications
Papers in
-
- Nigella sativa pharmacological applications 8
-
- Curcumin's Biomedical Applications 4
- Co-authors
- Hany H. ArabHany A. OmarWafaa R. MohamedSamir A. SalamaIbrahim A. MaghrabiBassant M. BarakatManal BuabeidAltaf A. Wani
- Journals
- International Immunopharmacology (3 papers)Toxicology and Applied Pharmacology (3 papers)Life Sciences (3 papers)PLoS ONE (3 papers)Pharmaceuticals (2 papers)
- Partner nations
- EgyptUnited Arab EmiratesSaudi Arabia
In The Last Decade
El‐Shaimaa A. Arafa
59 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 122
- Toxicology 136
- Complementary and alternative medicine 266
- Pharmacology 275
- Biochemistry 172
- Pathology and Forensic Medicine 303
Countries citing papers authored by El‐Shaimaa A. Arafa
This map shows the geographic impact of El‐Shaimaa A. Arafa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by El‐Shaimaa A. Arafa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites El‐Shaimaa A. Arafa more than expected).
Fields of papers citing papers by El‐Shaimaa A. Arafa
This network shows the impact of papers produced by El‐Shaimaa A. Arafa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by El‐Shaimaa A. Arafa. The network helps show where El‐Shaimaa A. Arafa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside El‐Shaimaa A. Arafa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 24 | |
| 4 | 2023 | 13 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 48 | |
| 7 | 2021 | 25 | |
| 8 | 2021 | 21 | |
| 9 | 2021 | 14 | |
| 10 | 2020 | 2 | |
| 11 | 2019 | 23 | |
| 12 | 2015 | 6 | |
| 13 | 2015 | 217 | |
| 14 | 2015 | 89 | |
| 15 | 2015 | 14 | |
| 16 | 2014 | 92 | |
| 17 | 2014 | 27 | |
| 18 | 2009 | 117 | |
| 19 | Thymoquinone upregulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells | 2008 | 2 |
| 20 | 2007 | 75 |
About El‐Shaimaa A. Arafa
El‐Shaimaa A. Arafa is a scholar working on Complementary and alternative medicine, Molecular Medicine, Pharmacology, Toxicology and Geriatrics and Gerontology, having authored 63 papers that have together received 2.1k indexed citations. Recurring topics across this work include Nigella sativa pharmacological applications (8 papers), Chemotherapy-induced organ toxicity mitigation (8 papers), Genomics, phytochemicals, and oxidative stress (4 papers), Nanoparticles: synthesis and applications (4 papers), Curcumin's Biomedical Applications (4 papers), Autophagy in Disease and Therapy (4 papers), Metabolism, Diabetes, and Cancer (3 papers) and Heavy Metal Exposure and Toxicity (3 papers). The work is most often cited by research in Toxicology (136 citations), Complementary and alternative medicine (266 citations), Pharmacology (275 citations), Biochemistry (172 citations) and Pathology and Forensic Medicine (303 citations). El‐Shaimaa A. Arafa has collaborated with scholars based in Egypt, United Arab Emirates and Saudi Arabia. Frequent co-authors include Hany H. Arab, Hany A. Omar, Wafaa R. Mohamed, Samir A. Salama, Ibrahim A. Maghrabi, Bassant M. Barakat, Manal Buabeid, Altaf A. Wani, Gulzar Wani and Mohamed A. El‐Mahdy. Their work appears in journals such as International Immunopharmacology, Toxicology and Applied Pharmacology, Life Sciences, PLoS ONE and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.